These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Research, in a sample of the population of Asmara (Eritrea), on antibodies neutralizing some types of enterovirus (poliovirus 1, 2 and 3; Coxsackie virus B 1 to B 5; ECHO virus 9, 11, and 12)]. Sebastiani A, Taglieri G, Balestrieri A. Acta Med Ital Med Trop Subtrop Gastroenterol; 1965; 20(4):29-33. PubMed ID: 5181044 [No Abstract] [Full Text] [Related]
7. [The latex agglutination-inhibition test: a method for rapid antibody determination after enterovirus infection (author's transl)]. Schmidt WA, Brade H, Klein M. Dtsch Med Wochenschr; 1974 Oct 18; 99(42):2099-103. PubMed ID: 4372023 [No Abstract] [Full Text] [Related]
8. The presence of ECHO 9 antibodies in the young population of different regions in Serbia. Stojković L, Kanjuh B. J Hyg Epidemiol Microbiol Immunol; 1967 Oct 18; 11(1):5-8. PubMed ID: 4294057 [No Abstract] [Full Text] [Related]
9. Bovine enteric cytopathogenic viruses. II. Neutralization studies with human sera. Rovozzo GC, Luginbuhl RE. Cornell Vet; 1965 Oct 18; 55(4):567-75. PubMed ID: 4159413 [No Abstract] [Full Text] [Related]
10. Antibodies to echovirus type 30 in the Canadian population. Duncan IB. Can Med Assoc J; 1968 Oct 26; 99(16):786-90. PubMed ID: 4176074 [No Abstract] [Full Text] [Related]
11. Assessment of efficacy of a live oral poliovirus vaccine for virulent Sabin-like poliovirus 1 strains in Japan. Iwai M, Nakayama T, Matsuura K, Hasegawa S, Ando S, Obara M, Nagai Y, Yoshida H, Horie H. Acta Virol; 2006 Oct 26; 50(2):139-43. PubMed ID: 16808333 [Abstract] [Full Text] [Related]
12. [Studies on serological response of attenuated live poliovirus vaccine. 1. On neutralizing antibodies affected by various dosage methods]. Kami Y. Kumamoto Igakkai Zasshi; 1966 Aug 25; 40(8):881-97. PubMed ID: 5953627 [No Abstract] [Full Text] [Related]
13. [Changes in antibody titers against an enterovirus (ECHO 22) in North Bavaria in relation to mortality from heart disease 1977 to 1981]. Moldenhauer D. Zentralbl Bakteriol Mikrobiol Hyg B; 1984 Jan 25; 178(5-6):502-9. PubMed ID: 6326426 [Abstract] [Full Text] [Related]
14. [Behavior of poliovirus neutralizing antibodies in 108 subjects vaccinated with the Sabin vaccine]. Andreoni G, Curatolo D, Cervini E, Rocchi G, Velli V. G Mal Infett Parassit; 1966 Oct 25; 18(10):653-7. PubMed ID: 5997193 [No Abstract] [Full Text] [Related]
18. [A study of neutralizing antibodies against various enteroviruses in various age groups of the population of Leningrad]. Nikolaev VP. Vopr Virusol; 1966 Oct 25; 11(3):307-11. PubMed ID: 6002850 [No Abstract] [Full Text] [Related]
19. Evaluation of a two-dose administration of live oral poliovirus vaccine for wild and virulent vaccine-derived poliovirus type 1, 2, 3 strains in Japan. Iwai M, Takizawa T, Nakayama T, Matsuura K, Yoshida H, Hasegawa S, Obara M, Horimoto E, Kurata T, Horie H. Scand J Infect Dis; 2008 Oct 25; 40(3):247-53. PubMed ID: 17907043 [Abstract] [Full Text] [Related]
20. A seroprevalence study of poliovirus antibody in the population of northern Greece. Frantzidou F, Diza E, Halkia D, Antoniadis A. Clin Microbiol Infect; 2005 Jan 25; 11(1):68-71. PubMed ID: 15649308 [Abstract] [Full Text] [Related] Page: [Next] [New Search]